Moore, Kelvin
Tourneau, Noelle Le
Alvarez, Jasmin
Rodriguez, Santos
Broussard, Janessa
Crouch, Pierre-Cédric
Roman, Jorge
Defechereux, Patricia
Bena, Jason
Koester, Kimberly A.
Moran, Lissa
Pilcher, Christopher
Grant, Robert
Christopoulos, Katerina A.
Funding for this research was provided by:
California HIV/AIDS Research Program
National Institute of Allergy and Infectious Diseases (K24AI167805)
Article History
Received: 8 October 2024
Accepted: 20 December 2024
First Online: 6 January 2025
Declarations
:
: This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) at the University of California, San Francisco (UCSF). The study protocol was reviewed and approved under CHR# 18-25758. Informed consent was waived for study participants because remnant specimens were used, presenting minimal risk to participants and adhering to ethical guidelines while still respecting patient autonomy. Staff provided informed consent to participate in interviews outside of work hours and were compensated $50.
: We have received informed consent for publication.
: Dr. Christopoulos has been a medical advisory board member for Gilead Sciences and a workshop participant for Janssen.
: The authors declare no competing interests.